Skip to content

Acadia Healthcare ACHC Stock-Based Comp

Stock-Based Comp at other companies

Universal Health Services logo
Universal Health ServicesUHS
$22.5M+4.2%
HCA Healthcare logo
HCA HealthcareHCA
$86M-12.2%
LifeStance Health Group logo
LifeStance Health GroupLFST
$15.2M-18.2%
National Healthcare logo
National HealthcareNHC
$1.28M+24.6%
Astrana Health logo
Astrana HealthASTH
$9.9M+26.7%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$11.5M+21.1%

Other financials

Income statement

See full
Revenue$828.8M+7.6%
Net income$4.1M-51.0%
EPS (diluted)$0.05-44.4%

Balance sheet

See full
Cash & equivalents$158.5M+73.7%
Total debt$2.7B+14.7%
Total equity$2.0B-35.6%
Total assets$5.5B-9.8%

Cash flow

See full
Operating cash flow$61.5M+436%
CapEx$76.6M-56.2%
Free cash flow-$15.0M+90.8%

Valuation

See full
Market cap$2.26B-23.6%
Enterprise value$4.77B-7.7%
P/S0.7×-0.3×

Profitability

See full
Net margin-32.8%-38.8pp
FCF margin-8.7%-0.1pp

Returns & leverage

See full
Return on equity-44.3%-50.6pp
Debt / equity1.4×+0.6×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Acadia Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Acadia Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Healthcare's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Healthcare's stock-based comp?
Acadia Healthcare (ACHC) reported stock-based comp of $7.96M in Q1 2026.
How has Acadia Healthcare's stock-based comp changed year-over-year?
Acadia Healthcare's stock-based comp decreased by 8.3% year-over-year, from $8.68M to $7.96M.
What is the long-term trend for Acadia Healthcare's stock-based comp?
Over 4 years (2021 to 2025), Acadia Healthcare's stock-based comp has grown at a -4.1% compound annual growth rate (CAGR), from $37.53M to $31.71M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.